VKH
XENE icon

Virtu KCG Holdings’s Xenon Pharmaceuticals XENE Stock Holding History

Virtu KCG Holdings’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$74K Sell
23,367
-7,040
-23% -$27.5K ﹤0.01% 2497
2017
Q1 		$122K Buy
+30,407
New +$239K ﹤0.01% 2622

Other funds holding XENE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Virtu KCG Holdings's XENE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Xenon Pharmaceuticals (XENE) stake by 23% in Q2 2017, selling an estimated $27.5K and leaving 23,367 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

Virtu KCG Holdings first reported a position in XENE in Q1 2017 and has held it in 2 quarters since. The position peaked at $122K in Q1 2017. 39 funds tracked by Wall St. Rank hold XENE as of Q2 2017.

  • Virtu KCG Holdings held 23,367 shares of Xenon Pharmaceuticals worth $74K as of Q2 2017.
  • Virtu KCG Holdings sold 7,040 Xenon Pharmaceuticals shares in Q2 2017, an estimated $27.5K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2497 holding.
  • Virtu KCG Holdings first reported a position in Xenon Pharmaceuticals in Q1 2017 and has held it in 2 quarters since.
  • Virtu KCG Holdings's Xenon Pharmaceuticals position peaked at $122K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.